Dianhydrogalactitol (Val-083) synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells These types of reports bother me because we can't just try them right now. It seems to make sense, and works in mice but it will be years before most people could try it. It will unfortunately be too late for most people who currently have a glioblastoma.
However, if our "Promising Pathway Act" was passed, drugs like Val-083 would be approved and easily available, and we could try combining them with a few different topoisomerase drugs, record the outcomes in the registry and quickly learn the best way to use it. This is a much faster pathway to the cure. We need your help getting it passed. Go to https://virtualtrials.com/activism.cfm for details and to easily send letters to your congresspeople.
An Emerging Medical Market Play with Great Opportunity An Emerging Medical Market Play with Great Opportunity This is a paid advertisement (to the Stockhouse newsletter - not to us!) I usually never would reprint one of these in our brain tumor news blast as they are usually designed to just pump up stock prices, however it mentions an important new technology. This is a new platform that enables drugs to pass through the blood brain barrier. Could be useful not only for brain cancer but other brain diseases like Alzheimer’s. Will be keeping an eye on this.
